| Multiple Sclerosis |
1 |
1 |
| Exercise |
0 |
0.83 |
| Aspirin |
0 |
0.62 |
| Healthcare and Medical Technology |
0 |
0.15 |
| Patient Safety |
0 |
0.15 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.15 |
| Adverse Effects |
0 |
0.07 |
| Canada |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Hypothalamus |
0 |
0.07 |
| New York |
0 |
0.07 |
| Relapsing Remitting Multiple Sclerosis |
0 |
0.99 |
| Weakness |
0 |
0.07 |